Table 4.
Outcome Measure | Diastolic Eccentricity Index | P Value | Systolic Eccentricity Index | P Value | Maximum Eccentricity Index | P Value | Diastolic RV:LV Ratio | P Value | Systolic RV:LV Ratio | P Value |
---|---|---|---|---|---|---|---|---|---|---|
Death | 3.49 (0.06-212.56) | 0.55 | 1.41 (0.08-25.68) | 0.81 | 1.35 (0.19-9.86) | 0.77 | 7.04 (0.31-236.85) | 0.28 | 2.91 (0.55-15.50) | 0.21 |
Transplant | 0.011 (0-999.99) | 0.39 | 0.31 (0.01-58.95) | 0.66 | 0.83 (0.05-14.45) | 0.90 | 0.08 (0-212.34) | 0.53 | 0.74 (0.05-12.93) | 0.84 |
PH Hospitalization | 17.77 (1.63-193.84) | 0.0183 | 15.31 (2.73-85.95) | 0.0019 | 5.57 (1.74-17.81) | 0.0038 | 11.14 (1.44-86.26) | 0.0209 | 3.99 (1.39-11.40) | 0.0099 |
Therapy Escalation | 8.80 (0.59-131.96) | 0.12 | 4.32 (0.96-19.53) | 0.06 | 5.62 (1.42-22.24) | 0.0140 | 12.27 (0.83-181.80) | 0.07 | 3.99 (1.13-14.14) | 0.0321 |
6MWD | −0.37 (−0.62 - −0.05) | 0.0264 | −0.24 (−0.53-0.10) | 0.16 | −0.29 (−0.57-0.04) | 0.08 | −0.16 (−0.46-0.18) | 0.35 | −0.14 (−0.45-0.19) | 0.41 |
BNP | 0.50 (0.27-0.67) | <0.0001 | 0.29 (0.04-0.51) | 0.0259 | 0.29 (0.03-0.52) | 0.0275 | 0.45 (0.22-0.64) | 0.0003 | 0.38 (0.13-0.58) | 0.0040 |
NT-Pro BNP | 0.50 (0.27-0.67) | <0.0001 | 0.32 (0.07-0.54) | 0.0138 | 0.35 (0.10-0.56) | 0.0074 | 0.49 (0.26-0.67) | <0.0001 | 0.43 (0.19-0.63) | 0.0008 |
WHO class | 0.45 (0.23-0.63) | 0.0002 | 0.58 (0.38-0.72) | <0.0001 | 0.62 (0.43-0.75) | <0.0001 | 0.49 (0.27-0.66) | <0.0001 | 0.63 (0.45-0.76) | <0.0001 |
Death, Transplant, PH Hospitalization, and Therapy Escalation were evaluated using logistic regression. Data are presented as odds ratio (95% confidence interval).
6MWD, BNP, pro-BNP, and WHO class were evaluated using Spearman correlation coefficients. Data are presented as correlation coefficient (95% confidence interval).
6MWD = 6-minute walk distance; BNP = brain natriuretic peptide; LV = left ventricle; NT-Pro BNP = N-terminal pro-BNP; PH = pulmonary hypertension; RV = right ventricle; WHO = world health organization.